It is well known that GM-CSF gene deficient animals show resistance towards EAE induction38, and the administration of neutralising antibody GM-CSF (MOR103) to MS patients led to reduced lesion activity in the CNS39. This evidence concerns the gene CSF2 and myeloid sarcoma.